Literature DB >> 1529103

Animal and drug modelling for Alzheimer synaptic pathology.

P T Francis1, M N Pangalos, D M Bowen.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1529103     DOI: 10.1016/0301-0082(92)90005-y

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


× No keyword cloud information.
  5 in total

1.  Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635.

Authors:  C Balducci; M Nurra; A Pietropoli; R Samanin; M Carli
Journal:  Psychopharmacology (Berl)       Date:  2003-03-05       Impact factor: 4.530

2.  Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.

Authors:  P T Francis; M N Pangalos; P H Stephens; J R Bartlett; P K Bridges; A L Malizia; D Neary; A W Procter; D J Thomas; D M Bowen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

3.  Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegans.

Authors:  Marishka K Brown; Yuan Luo
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

4.  Chronic NMDA receptor stimulation: therapeutic implications of its effect on adenosine A1 receptors.

Authors:  D K Von Lubitz; J Kim; M Beenhakker; M F Carter; R C Lin; Y Meshulam; J W Daly; D Shi; L M Zhou; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

5.  Exercise benefits brain function: the monoamine connection.

Authors:  Tzu-Wei Lin; Yu-Min Kuo
Journal:  Brain Sci       Date:  2013-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.